BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 36912997)

  • 1. Linking the relation between gut microbiota and glucocorticoid-induced osteoporosis.
    Zhou RX; Zhang YW; Cao MM; Liu CH; Rui YF; Li YJ
    J Bone Miner Metab; 2023 Mar; 41(2):145-162. PubMed ID: 36912997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A narrative review of the moderating effects and repercussion of exercise intervention on osteoporosis: ingenious involvement of gut microbiota and its metabolites.
    Zhang YW; Cao MM; Li YJ; Chen XX; Yu Q; Rui YF
    J Transl Med; 2022 Oct; 20(1):490. PubMed ID: 36303163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuna Bone Powder Alleviates Glucocorticoid-Induced Osteoporosis via Coregulation of the NF-κB and Wnt/β-Catenin Signaling Pathways and Modulation of Gut Microbiota Composition and Metabolism.
    Li J; Yang M; Lu C; Han J; Tang S; Zhou J; Li Y; Ming T; Wang ZJ; Su X
    Mol Nutr Food Res; 2020 Mar; 64(5):e1900861. PubMed ID: 31953894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption.
    Ren Z; Yang L; Xue F; Meng Q; Wang K; Wu X; Ji C; Jiang T; Liu D; Zhou L; Zhang J; Fu Q
    Biol Trace Elem Res; 2013 Jun; 152(3):396-402. PubMed ID: 23532566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures.
    Gourlay M; Franceschini N; Sheyn Y
    Clin Rheumatol; 2007 Feb; 26(2):144-53. PubMed ID: 16670825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modulatory effect and implication of gut microbiota on osteoporosis: from the perspective of "brain-gut-bone" axis.
    Zhang YW; Li YJ; Lu PP; Dai GC; Chen XX; Rui YF
    Food Funct; 2021 Jul; 12(13):5703-5718. PubMed ID: 34048514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid-Induced Osteoporosis.
    Schepper JD; Collins F; Rios-Arce ND; Kang HJ; Schaefer L; Gardinier JD; Raghuvanshi R; Quinn RA; Britton R; Parameswaran N; McCabe LR
    J Bone Miner Res; 2020 Apr; 35(4):801-820. PubMed ID: 31886921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for glucocorticoid-induced osteoporosis.
    Chiodini I; Merlotti D; Falchetti A; Gennari L
    Expert Opin Pharmacother; 2020 Apr; 21(6):721-732. PubMed ID: 32004105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
    Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
    Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High fracture risk patients with glucocorticoid-induced osteoporosis should get an anabolic treatment first.
    Lespessailles E; Chapurlat R
    Osteoporos Int; 2020 Oct; 31(10):1829-1834. PubMed ID: 32780152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.
    Hayes KN; Baschant U; Hauser B; Burden AM; Winter EM
    Front Endocrinol (Lausanne); 2021; 12():782118. PubMed ID: 34975756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis].
    Kaneko K; Kawai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):138-48. PubMed ID: 21720102
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li S; Han X; Liu N; Chang J; Liu G; Hu S
    Front Immunol; 2023; 14():1285442. PubMed ID: 38264658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucocorticoid and Bone. Collagen cross-link abnormalities in glucocorticoid induced osteoporosis].
    Saito M; Marumo K
    Clin Calcium; 2014 Sep; 24(9):1351-9. PubMed ID: 25177008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced Osteoporosis.
    Whittier X; Saag KG
    Rheum Dis Clin North Am; 2016 Feb; 42(1):177-89, x. PubMed ID: 26611558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbial community and fecal metabolomic signatures in different types of osteoporosis animal models.
    Qiao X; Li X; Wang Z; Feng Y; Wei X; Li L; Pan Y; Zhang K; Zhou R; Yan L; Li P; Xu C; Lv Z; Tian Z
    Aging (Albany NY); 2024 Jan; 16(2):1192-1217. PubMed ID: 38284894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced osteoporosis: 2019 concise clinical review.
    Adami G; Saag KG
    Osteoporos Int; 2019 Jun; 30(6):1145-1156. PubMed ID: 30805679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of Glucocorticoid-Induced Osteoporosis Preventive Care in Korea: A Retrospective Cohort Study on the Korean National Health Insurance Service Database.
    Song BW; Kim AR; Kim MA; Kim HS; Lee SG
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.